Grandfield & Dodd’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-7,016
| Closed | -$1.29M | – | 213 |
|
2021
Q2 | $1.29M | Sell |
7,016
-356
| -5% | -$65.5K | 0.09% | 89 |
|
2021
Q1 | $1.13M | Sell |
7,372
-95
| -1% | -$14.6K | 0.08% | 91 |
|
2020
Q4 | $1.17M | Buy |
7,467
+300
| +4% | +$47K | 0.09% | 89 |
|
2020
Q3 | $820K | Buy |
7,167
+145
| +2% | +$16.6K | 0.07% | 101 |
|
2020
Q2 | $790K | Buy |
7,022
+670
| +11% | +$75.4K | 0.08% | 104 |
|
2020
Q1 | $570K | Buy |
6,352
+502
| +9% | +$45K | 0.07% | 109 |
|
2019
Q4 | $633K | Buy |
5,850
+705
| +14% | +$76.3K | 0.06% | 118 |
|
2019
Q3 | $504K | Buy |
5,145
+685
| +15% | +$67.1K | 0.05% | 130 |
|
2019
Q2 | $584K | Buy |
4,460
+432
| +11% | +$56.6K | 0.06% | 121 |
|
2019
Q1 | $545K | Buy |
4,028
+72
| +2% | +$9.74K | 0.06% | 125 |
|
2018
Q4 | $385K | Buy |
3,956
+76
| +2% | +$7.4K | 0.05% | 132 |
|
2018
Q3 | $539K | Buy |
3,880
+35
| +0.9% | +$4.86K | 0.06% | 125 |
|
2018
Q2 | $477K | Buy |
3,845
+30
| +0.8% | +$3.72K | 0.05% | 129 |
|
2018
Q1 | $425K | Sell |
3,815
-30
| -0.8% | -$3.34K | 0.05% | 138 |
|
2017
Q4 | $460K | Buy |
3,845
+60
| +2% | +$7.18K | 0.05% | 141 |
|
2017
Q3 | $531K | Buy |
3,785
+425
| +13% | +$59.6K | 0.06% | 127 |
|
2017
Q2 | $409K | Buy |
3,360
+90
| +3% | +$11K | 0.05% | 144 |
|
2017
Q1 | $396K | Buy |
3,270
+47
| +1% | +$5.69K | 0.05% | 141 |
|
2016
Q4 | $394K | Buy |
3,223
+385
| +14% | +$47.1K | 0.05% | 140 |
|
2016
Q3 | $348K | Buy |
2,838
+225
| +9% | +$27.6K | 0.05% | 146 |
|
2016
Q2 | $305K | Buy |
2,613
+114
| +5% | +$13.3K | 0.04% | 149 |
|
2016
Q1 | $348K | Buy |
2,499
+940
| +60% | +$131K | 0.05% | 133 |
|
2015
Q4 | $297K | Buy |
+1,559
| New | +$297K | 0.05% | 145 |
|
2015
Q3 | – | Sell |
-1,240
| Closed | -$224K | – | 179 |
|
2015
Q2 | $224K | Hold |
1,240
| – | – | 0.03% | 161 |
|
2015
Q1 | $215K | Hold |
1,240
| – | – | 0.03% | 157 |
|
2014
Q4 | $229K | Sell |
1,240
-9
| -0.7% | -$1.66K | 0.04% | 153 |
|
2014
Q3 | $207K | Buy |
+1,249
| New | +$207K | 0.03% | 157 |
|